The store will not work correctly when cookies are disabled.
3-(3-chlorophenyl)-2-isobutyl-10-methylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione
ID: ALA4784143
PubChem CID: 85090339
Max Phase: Preclinical
Molecular Formula: C22H20ClN3O2
Molecular Weight: 393.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1nc2c(c(=O)c3ccccc3n2C)c(=O)n1-c1cccc(Cl)c1
Standard InChI: InChI=1S/C22H20ClN3O2/c1-13(2)11-18-24-21-19(20(27)16-9-4-5-10-17(16)25(21)3)22(28)26(18)15-8-6-7-14(23)12-15/h4-10,12-13H,11H2,1-3H3
Standard InChI Key: PJCKLAREXGOOSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
10.3606 -15.1660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3595 -15.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0743 -16.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0724 -14.7532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7878 -15.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7886 -15.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5038 -16.4002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4982 -14.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2141 -15.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2177 -15.9850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9367 -16.3949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6528 -15.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6451 -15.1435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9254 -14.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4938 -13.9233 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9183 -13.9125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3503 -14.7253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0689 -15.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7789 -14.7142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7716 -13.8883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0481 -13.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3412 -13.9037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3656 -16.3826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3696 -17.2085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0831 -17.6157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6573 -17.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4971 -15.1202 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.5061 -17.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
24 25 1 0
12 23 1 0
24 26 1 0
19 27 1 0
7 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.87 | Molecular Weight (Monoisotopic): 393.1244 | AlogP: 4.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 56.89 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.49 | Np Likeness Score: -1.15 |
References
1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389] [10.1016/j.bmcl.2020.127696] |